EDN1 and obstructive sleep apnea syndrome: In OSA, recurrent hypoxia is experienced, driving the ET-1 release through HIF-1a signalling and oxidative stress, culminating in a 50% rise in ET-1 within the plasma (Gjørup et al. 2007).